JPM vs. LLY: JPMorgan Chase vs. Eli Lilly Stock Comparison

Company Profile

JPMorgan Chase (JPM) is classified in the Financials sector (Banks), whereas Eli Lilly (LLY) belongs to Health Care (Pharmaceuticals, Biotechnology & Life Sciences) — their GICS classifications point to very different parts of the market.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Both JPMorgan Chase (JPM) at 18.01% and Eli Lilly (LLY) at 86.02% sit in the top peer quartile for ROE, suggesting each generates more profit from shareholders’ equity than typical industry peers.

Eli Lilly (LLY) at 31.90% converts revenue to bottom-line profit above its industry’s benchmark range, while JPMorgan Chase (JPM) at 34.59% keeps roughly the typical share for its industry.

Eli Lilly (LLY) reports operating margin of 53.66%; JPMorgan Chase (JPM) doesn’t report a comparable line — in Banks, funding costs sit inside the core business rather than below an operating line, so profitability is better judged on net margin or ROE.

Profitability Metrics

Growth

Both JPMorgan Chase (JPM) at 7.32% and Eli Lilly (LLY) at 44.70% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Eli Lilly (LLY) at 95.99% sits in the top EPS growth quartile, while JPMorgan Chase (JPM) at 1.37% is in the bottom quartile, showing a clear gap in earnings momentum.

Growth Metrics

Financial Strength

Eli Lilly (LLY) shows current ratio of 1.39; JPMorgan Chase (JPM) doesn’t get one — Banks balance sheets aren’t split into current and non-current buckets, so short-term liquidity there is judged through regulatory measures instead.

Eli Lilly (LLY) shows debt-to-equity ratio of 1.23; for JPMorgan Chase (JPM) the ratio is set aside — in Banks, balance-sheet leverage is part of the business model itself, so capital-adequacy measures do the job this ratio does elsewhere.

Financial Strength Metrics

Dividends

JPMorgan Chase (JPM) at 1.82% pays an industry-typical yield; Eli Lilly (LLY) at 0.49% is above its entire peer range — the higher number, but one that calls for a look at payout sustainability before treating it as an advantage.

JPMorgan Chase (JPM) at 25.80% keeps its payout in the industry’s typical band, while Eli Lilly (LLY) at 21.71% pays out more than any of its peers — the most stretched cover in its group.

Dividend Metrics

Valuation

Both JPMorgan Chase (JPM) at 14.03 and Eli Lilly (LLY) at 43.95 sit in the richer earnings-multiple quartile for P/E ratio, so investors are paying more for TTM earnings than they pay for typical peers.

Eli Lilly (LLY) shows P/S ratio of 13.95; for JPMorgan Chase (JPM) the multiple is skipped — in Banks, income is dominated by interest spread rather than a conventional revenue line, so pricing per dollar of sales loses meaning and book- or earnings-based multiples carry the comparison.

Measured against book value, both JPMorgan Chase (JPM) at 2.53 and Eli Lilly (LLY) at 29.96 look expensive — each P/B ratio sits above its industry’s benchmark range.

Valuation Metrics